Bellevue Group AG - CYTOKINETICS INC ownership

CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 263 filers reported holding CYTOKINETICS INC in Q1 2023. The put-call ratio across all filers is 0.99 and the average weighting 0.3%.

Quarter-by-quarter ownership
Bellevue Group AG ownership history of CYTOKINETICS INC
ValueSharesWeighting
Q3 2023$1,092,966
-9.7%
37,1000.0%0.02%
+5.9%
Q2 2023$1,210,202
-36.5%
37,100
-31.5%
0.02%
-39.3%
Q1 2023$1,907,298
-23.2%
54,2000.0%0.03%
-15.2%
Q4 2022$2,483,444
-28.0%
54,200
-23.9%
0.03%
-34.0%
Q3 2022$3,450,000
+32.2%
71,200
+7.2%
0.05%
+35.1%
Q2 2022$2,609,000
+2.7%
66,400
-3.8%
0.04%
+27.6%
Q1 2022$2,540,00069,0000.03%
Other shareholders
CYTOKINETICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
BVF INC/IL 2,106,989$14,159,0002.50%
Healthcare Value Capital, LLC 100,000$672,0000.71%
First Light Asset Management, LLC 218,792$1,470,0000.69%
IRONWOOD INVESTMENT MANAGEMENT LLC 435,202$2,925,0000.67%
TFS CAPITAL LLC 899,951$6,048,0000.59%
SPHERA FUNDS MANAGEMENT LTD. 422,250$2,838,0000.28%
ALGERT GLOBAL LLC 73,181$492,0000.27%
LANSDOWNE PARTNERS (UK) LLP 2,321,865$15,603,0000.13%
Leisure Capital Management 17,567$118,0000.12%
Rotella Capital Management, Inc. 15,778$106,0000.09%
View complete list of CYTOKINETICS INC shareholders